ManuPharma 2018

05 - 06 December, 2018

Steigenberger Frankfurter Hof, Frankfurt

Contact Us: 44 (0) 207 036 1363

Agenda Day 2

8:15 am - 8:55 am Networking Coffee

8:55 am - 9:00 am Chair’s opening remarks

Dieter Peters - SVP Operations Grünenthal
img

Dieter Peters

SVP Operations
Grünenthal

9:00 am - 9:20 am KEYNOTE CASE STUDY - How to adapt your manufacturing operations to meet the rapidly changing supply chain requirements of personalised and stratified medicine products

Michael Schneider - Head of Strategy - Manufacturing Science & Technology Roche
img

Michael Schneider

Head of Strategy - Manufacturing Science & Technology
Roche

9:20 am - 10:00 am PANEL DISCUSSION – How can you invest in and scale up industry 4.0 technology to better monitor in real-time and improve the efficacy of manufacturing projects, and what is the best way to achieve this scale up?

Ulf Schrader - Principal Consultant McKinsey

Ulf Schrader

Principal Consultant
McKinsey

10:00 am - 10:35 am OUT OF INDUSTRY CASE STUDY INTERACTIVE- How to implement integrated work systems that start with manufacturing and roll out across the end-to-end supply chain to increase reliability, performance and productivity on a global scale

10:35 am - 10:55 am CASE STUDY - How to implement standardisation both internally and in collaboration with your technology partners to develop more effective manufacturing processes

Josef Trapl - Global Head of Technology - Engineering and Manufacturing Takeda

Josef Trapl

Global Head of Technology - Engineering and Manufacturing
Takeda

10:55 am - 11:30 am Networking break

10:55 am - 11:30 am MASTERCLASS 2

Track A - Ecosystem and partnerships

11:30 am - 12:10 pm CASE STUDY INTERACTIVE - How to implement operational excellence principles in a range of pharma manufacturing sites and significantly save costs using a process of standardisation
Matthew Gill - Director Operations Excellence Abbvie
img

Matthew Gill

Director Operations Excellence
Abbvie

API & ADI synthesis
Thomas Wickert, Director Manufacturing, Roche Diagnostics 3
Rare disease treatment manufacture
Clean room technology
Pilot plants
Site prioritisation
Continuous process verification
CMO partnerships in challenging geos
Silke Gotthardt, VP Launch Transfer Operations, Boehringer Ingelheim
Process Advanced Technology (PAT)
Lean manufacturing and six sigma
Reserved for Marco Maioli, Industrial Operations Director, Sigma Tau

Thomas Wickert

Head of Microbial Fermentation & Enzymes
Roche Diagnostics

img

Silke Gotthardt

VP Launch Transfer Operations
Boehringer Ingelheim

img

Marco Maioli

Industrial Operations Director
Sigma-Tau

MES & Infotech Interactive Workshops

11:30 am - 12:10 pm INTERACTIVE WORKSHOP – How to use best practice data analytics for predictive site maintenance to improve the stability of your production processes and CPV methods
Martin Fusek - Global Head of IT Testing Service Novartis
img

Martin Fusek

Global Head of IT Testing Service
Novartis

Manufacturing Leaders Boardroom

11:30 am - 1:00 pm A closed door invitation only boardroom style session reserved for Global Heads of Manufacturing, Global Heads of Tech Ops and SVP level representatives of pharma companies

1:00 pm - 1:50 pm Networking lunch

TRACK A - Changing Portfolios and Personalised Medicines

1:50 pm - 2:00 pm Chairman’s remarks
Dr. Helge Berg - Director BioManufacturing Science Network Europe Merck
img

Dr. Helge Berg

Director BioManufacturing Science Network Europe
Merck

TRACK A - Changing Portfolios and Personalised Medicines

2:00 pm - 2:40 pm PANEL DISCUSSION - Change management: What key principles should you implement and how can you best influence your workforce to drive a large scale manufacturing transformation project?
Klaus Kunath - Head of Manufacturing Science & Technology, Global Pharma Operations, Merck Merck KGaA Edwin Stoel - Chief Operating Officer Bioforce AG
img

Klaus Kunath

Head of Manufacturing Science & Technology, Global Pharma Operations, Merck
Merck KGaA

img

Edwin Stoel

Chief Operating Officer
Bioforce AG

TRACK A - Changing Portfolios and Personalised Medicines

2:40 pm - 3:20 pm CASE STUDY INTERACTIVE - How to use the most efficient cleaning and decontamination methods to support the production agility required by small volume product manufacture and reduce down time

Data & Site Connectivity Workshops

1:50 pm - 2:40 pm INTERACTIVE WORKSHOP - How to use cloud-based IT systems and connected sites to successfully meet the validation and quality requirements outlined by the regulators

Data & Site Connectivity Workshops

2:40 pm - 3:20 pm CASE STUDY INTERACTIVE - How to ensure standardisation and cost control of manufacturing operations during mergers and acquisitions activity
Marco Maioli - Industrial Operations Director Sigma-Tau
img

Marco Maioli

Industrial Operations Director
Sigma-Tau

Creative Boardrooms

1:50 pm - 3:20 pm DIVERSITY IN PHARMA MANUFACTURING BOARDROOM – How can you best, empower and promote the equality of your workforce’s gender and ethnicity?

3:20 pm - 3:50 pm Networking Break

TRACK A - Changing Portfolios and Personalised Medicines

3:50 pm - 4:10 pm CASE STUDY - How to make critical assessment of CMOs and develop a matrix of action plans accordingly, in order to de-risk your manufacturing network in the context of EU FMD implementation
Marcelo Costa - Global Head of FMD STADA
img

Marcelo Costa

Global Head of FMD
STADA

TRACK A - Changing Portfolios and Personalised Medicines

4:10 pm - 4:30 pm PANEL DISCUSSION – PAT and QbD: How can you use PAT, best practice tech transfer and QbD to ensure you meet the regulatory and business requirements for product release?
Heike Abeck - Director Manufacturing Sciences & Technology Bayer
img

Heike Abeck

Director Manufacturing Sciences & Technology
Bayer

Data & Site Connectivity Workshops

3:50 pm - 4:30 pm INTERACTIVE WORKSHOP – MES: How to develop a successful supplier management strategy to ensure your MES processes are compliant and cost-effective

4:30 pm - 5:00 pm End of conference